Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Pioglitazone MeSH Descriptor Data 2025


MeSH Heading
Pioglitazone
Tree Number(s)
D02.886.675.933.250
D03.383.129.708.933.250
Unique ID
D000077205
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077205
Scope Note
A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
Entry Term(s)
5-(4-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
AD 4833
AD-4833
Actos
Pioglitazone Hydrochloride
U 72107A
U-72107A
U72,107A
Pharm Action
Hypoglycemic Agents
Registry Numbers
X4OV71U42S
0
JQT35NPK6C
Related Numbers
111025-46-8
112529-15-4
JQT35NPK6C
See Also
Rosiglitazone
Public MeSH Note
2019; PIOGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1989-2003
History Note
2019 (1989)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2019/05/17
Pioglitazone Preferred
AD 4833 Narrower
U 72107A Narrower
Pioglitazone Hydrochloride Narrower
Actos Narrower
page delivered in 0.146s